tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Ascentage Pharma Group International Unsponsored ADR (AAPG)
NASDAQ:AAPG
US Market
AAPG
Ascentage Pharma Group International Unsponsored ADR
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Advertisement

Ascentage Pharma Group International Unsponsored ADR (AAPG) Financial Statements

Compare
15 Followers

Ascentage Pharma Group International Unsponsored ADR Financial Overview

Ascentage Pharma Group International Unsponsored ADR's market cap is currently $4.26B. The company's EPS TTM is $-0.964; its P/E ratio is ―; Ascentage Pharma Group International Unsponsored ADR is scheduled to report earnings on August 20, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 980.65M¥ 221.98M¥ 209.71M¥ 4.33M¥ 12.45M
Gross Profit¥ 951.57M¥ 191.44M¥ 187.71M¥ 24.58M¥ 10.48M
Operating Income¥ -369.73M¥ -872.64M¥ -849.81M¥ -869.84M¥ -663.94M
EBITDA¥ -237.63M¥ -743.61M¥ -771.47M¥ -787.19M¥ -641.77M
Net Income¥ -405.43M¥ -925.64M¥ -882.92M¥ -782.42M¥ -677.61M
Balance Sheet
Cash & Short-Term Investments¥ 1.24B¥ 1.07B¥ 1.48B¥ 273.61M¥ 1.02B
Total Assets¥ 2.62B¥ 2.50B¥ 2.83B¥ 2.94B¥ 1.73B
Total Debt¥ 1.67B¥ 1.80B¥ 1.79B¥ 1.08B¥ 529.70M
Net Debt¥ 431.92M¥ 726.30M¥ 317.09M¥ -622.60M¥ -490.28M
Total Liabilities¥ 2.34B¥ 2.43B¥ 2.42B¥ 1.71B¥ 884.42M
Stockholders' Equity¥ 264.19M¥ 60.42M¥ 408.66M¥ 1.23B¥ 846.62M
Cash Flow
Free Cash Flow¥ -135.65M¥ -782.92M¥ -890.88M¥ -1.04B¥ -861.43M
Operating Cash Flow¥ -111.36M¥ -726.08M¥ -653.91M¥ -604.68M¥ -609.96M
Investing Cash Flow¥ -362.04M¥ 21.92M¥ -384.61M¥ -466.52M¥ -107.37M
Financing Cash Flow¥ 314.77M¥ 368.75M¥ 619.27M¥ 1.78B¥ 1.04B
Currency in CNY

Ascentage Pharma Group International Unsponsored ADR Earnings and Revenue History

Income Statement >

Ascentage Pharma Group International Unsponsored ADR Debt to Assets

Balance Sheet >

Ascentage Pharma Group International Unsponsored ADR Cash Flow

Cash Flow >

Ascentage Pharma Group International Unsponsored ADR Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis
Subscribe NowSee Plans & Pricing